Investment Q&A

Q: Hello team, I've been watching at these stocks (all US) for awhile and it seems I've missed the boat on all of them. If you happen to know about them, would you pls. give me your thoughts? Do you think they still have some upside?
Thank you!!

Q: Would like your opinion on crh,
lots of interest in this one out there,recent u.s. listing, added to
Sp/tsx small cap index, several$7
12 mo tgts. Thank you.

Q: Hello Peter et al
At what point do insiders have to cease buying company stock when they are in negotiations to take over another company? For example there has been a lot of insider buying of SYZ in the past 10 months including the purchase by the CEO of 12600 shares on 15 Sept. Does the recent purchase in effect confirm there are no takeover negotiations in progress?

Also would you consider calling a company such as SYZ in an effort to obtain a first hand impression of how the company is doing? Obviously they can only pass on publically released information but a person may be able to “read between the lines”.

We have about a 2% holding of SYZ and in view of the Q3 results and insider buying are anxious to buy more, but need a little shove to do so.

Many thanks for any comments. Bob

Q: Hello Peter and Team,
Would you prefer Starbucks or McDonalds for growth going forward, with a bit of explanation?
Thank You,
Barry

Q: I have owned CAE for a couple of years and despite winning contracts and continuing to lead the industry, the stock doesn't seem to be going anywhere (I am about break even). I am considering a switch to MDA but am wondering two things. Is MDA's risk profile substantially higher than CAE and secondly, the Canadian Stock Exchange website classifies CAE as an industrial stock and MDA as a tech stock. I have enough tech already but I would have thought these companies were actually quite similar and would have considered them both as industrials.

Your insight is always greatly appreciated

Paul F.

Q: As a recent IPO, dividend paying, growth by acquisition, relatively high ownership by CEO, in a high profile industry, would you consider RAY.A to be a reasonable, risky or speculative buy at this point? Has it caught your attention and what insight and opinion can you give, please?

Q: hi experts; onr.db.b can be bought for 88% onr.db.c for 101% the conversion price is $1 more for b .and 2 years less to convert. is this why the different pricing. thanks brian

Q: Hello Peter and Company,
Will the division of NRI into two companies enhance the total value? Should one hold ?
Thanks. Bill.

Q: This question was asked by Curtis on September 16th.
Your answer: We would opt for a more balanced portfolio, adding some tech, industrials, consumer products (which should be OK in a downturn) and other sectors.
Could you elaborate with one or two company names you would be comfortable with that would fit Curtis's vacation portfolio?
Would you keep REITS at 20% weight?
Thank you.

Q: Hi Peter

What biotech stocks do you prefer? Many seem to be breaking out based on point and figure charts. What biotechs would you recommend in terms of individual names and also what ETF do you prefer?

Thanks so much!

Q: your comments now that they've "coupled" with amazon. thanks

Q: Could I have a quick scorecard on this one ROE, debt, revenue growth or other metrics that are more suitable for this one and a possible grade. Thanks guys

Q: I think esports will be a huge growing industry over the coming decades. Do you know of any good public companies that are in this market that you could recommend for a long-term position?
I heard that CGX just bought an esports company, which I think was smart, but it is very small compared to the size of their business.

Thanks!

Q: My sector on health care needs to be increased. I am at 3% and would like it to be 5%. Please recommend a stock with dividends and some growth. Thanks. Ernie

Q: http://www.stockhouse.com/companies/bullboard/t.gud/knight-therapeutics-inc?postid=24101431

Mr. Hodson, is this connected with GUD ? If so, why is Advaxis not mentioned in the September 17, 2015 Company Report within Growth Plans (sampling of recent deals) ?
You may publish your response if you wish. Thanks for your attention.

Q: I own both ZIN down 14% and it is only 1% of my portfolio and ZIN down 3% and it is 2% of my portfolio, would you consider these 2 ETF good for the long term investor?

Q: Stock charts , or TMX money both allow you to compare performance between stocks in a sector / I find it helpful in getting a pulse .before buying .. Union Pacific and CNR both were battered , and I bought CNR at a recent low ... I didn't have enough USD but I would have bought Union Pacific as well... I have never lost on Rails ( touch wood ) . I follow ( CP, CNR, UNP.US, CSX.US ,NSC.US, KSU.US ) ... Making charts is easy, but doing due diligence on six companies is a day's work for me ... I would like to shorten my list / which are your faves ? ... and do you feel this reversal in rails has legs ?

Q: Hi Peter & Team,
The current ongoing acquisition that Concordia is doing is suppose to be 35% accretive to earnings in the first year. I assume that number is being calculated after the new debt and dilution of shares (with the equity raise), cash payouts and senergies are all factured in?
What is CXR's adjusted EPS range, total revenue, total debt, cash position before and after the acquisition?
Do you have an idea historically how much lower an equity raise price for a stock like this would be compared to current price (percentage wise)? I assume this will be done fairly quickly in the next few weeks?

Thank you, Shane

Q: I noticed the company subsidiary closed 2 deals with Nikon and Xerox, but the stock price has been steady. What is your take on the 2 agreements?
Thank you
Steve

Q: Results ?